Floatz logo

ROPIVACAINE

Anesthesia Morbidity

Umeå UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Anesthesia Morbidity cohort.

Asset / SponsorPhaseRating
Velpatasvir
Alexandria University
Phase 4BB
AUTOLOGOUS CONDITIONED PLASMA
Star Spine and Sport
Phase 4BB
Sofosbuvir
Alexandria University
Phase 4BB
NADROPARIN
Rijnstate Hospital
Phase 4BB
NEPENTHE
Hopital Lariboisière
Phase 4BB

View all 37 →

Same molecule, other indications

ROPIVACAINE is also rated in:

post-operative pain, non-human animalDormant
BBB
Indicative ·
76 / 100
View asset →
Knee Pain ChronicDormant
BBB
Indicative ·
76 / 100
View asset →
osteoarthritis, hipDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →